24/7 Customer Assistance
24/7 Assistance with the best medical care at your service
Call us for any question
+91 90858 83067BLOCK-B, PH-1, Sushant Lok Phase I, Gurugram, Haryana 122001
IndiaOffice Hour: 09:00am - 09:00pm
info@medigocare.comThere is a category of blindness that is different from most others: reversible. When the cornea — the clear dome at the very front of your eye that focuses light — becomes so scarred, clouded or misshapen that glasses can no longer fix what you see, a corneal transplant can replace it with healthy donor tissue and restore meaningful vision. For many patients who have spent years watching their sight fade through keratoconus, Fuchs' dystrophy, a corneal infection or an injury, that possibility carries enormous weight.
India is one of the world's most established destinations for corneal transplantation. With over 740 eye banks and eye donation centres registered under the Eye Bank Association of India, a national programme for controlling corneal blindness, and surgeons experienced in the full spectrum of modern techniques — from traditional full-thickness transplants to the latest ultra-thin DMEK grafts — it offers this hope at a fraction of what the same surgery costs in the United States or United Kingdom.
A note on terminology: When patients search for "eye transplant in India," they almost always mean a corneal transplant — keratoplasty. A whole-eye transplant is not currently possible in medicine. Only the cornea (the clear front surface) is replaced; the rest of the eye remains your own. This page covers everything you need to know about that procedure.
Cornea transplant cost in India ranges from approximately ₹50,000 to ₹2,50,000 per eye depending on the type of graft and the complexity of the case. The technique chosen — not the hospital's prestige — is the primary driver of cost, because different techniques require different levels of surgical skill and tissue preparation. These are indicative 2026 ranges; your exact all-inclusive quote is confirmed after a specialist reviews your corneal scans and diagnosis.
| Graft type | India (per eye) | In USD (approx.) | Used for |
|---|---|---|---|
| PK — full-thickness transplant | ₹50,000–₹1,50,000 | ~$600–$1,800 | Deep scarring, severe keratoconus, advanced disease |
| DALK — deep anterior lamellar | ₹70,000–₹1,50,000 | ~$840–$1,800 | Keratoconus, front-layer scarring, intact endothelium |
| DSEK / DSAEK — endothelial | ₹80,000–₹1,50,000 | ~$960–$1,800 | Fuchs' dystrophy, endothelial failure |
| DMEK — ultra-thin endothelial | ₹1,00,000–₹2,50,000 | ~$1,200–$3,000 | Fuchs' dystrophy, fastest visual recovery |
| Keratoprosthesis (artificial cornea) | Quoted case-by-case | ~$3,000–$5,000+ | Repeated graft failure, severe autoimmune cases |
*Indicative 2026 estimates. Most international patients at leading Indian centres pay between USD 1,500 and USD 4,000 all-inclusive.
Corneal transplant packages at our accredited partner hospitals typically cover: specialist consultation, pre-operative corneal assessments (topography, specular microscopy, OCT anterior segment), the surgical procedure, screened donor graft tissue from an accredited eye bank, anaesthetic, all in-hospital post-operative care, anti-rejection drops for the first course, and standard follow-up reviews during your stay in India. Remote teleconsultation follow-up is arranged once you return home — essential for the long monitoring period corneal transplants require. International flights and the visa fee sit outside the medical quote; MediGoCare provides your official hospital invitation letter and guides the visa application.
The cost difference between India and Western countries for corneal transplantation is among the largest of any major surgical procedure — larger even than for LASIK or cataract surgery. In the United States, a corneal transplant typically costs between USD 13,000 and USD 27,000 per eye when accounting for surgeon fees, hospital charges, donor tissue procurement and facility costs. In the UK private sector, equivalent procedures run approximately £6,000–£12,000 per eye. Beyond cost, NHS waiting lists for corneal transplantation in the UK can stretch to a year or more depending on tissue availability and specialist capacity.
| Country | PK (full-thickness) | DMEK (endothelial) | Wait for tissue |
|---|---|---|---|
| India | ~$600–$1,800/eye | ~$1,200–$3,000/eye | Days to weeks at leading centres |
| USA | ~$13,000–$20,000/eye | ~$17,000–$27,000/eye | Variable; often months |
| UK (private) | ~£6,000–£9,000/eye | ~£8,000–£12,000/eye | NHS: up to a year+ |
For patients from Nigeria, Kenya, Tanzania, Zimbabwe or other African nations — where advanced corneal sub-speciality care is scarce locally — India represents not just cost savings but access to techniques and equipment that may not be available at home. The same applies to patients with complex cases (advanced keratoconus, Fuchs' dystrophy, graft failure) who need a level of corneal expertise that is difficult to find in many countries.
We can quote in the currency most useful to you — USD, GBP, AED, NGN, KES, BDT or NPR. Send your diagnosis and scans on WhatsApp and we'll confirm a realistic all-inclusive figure.
The cornea is the transparent dome covering the front of the eye. When healthy, it is perfectly clear and gently curved, focusing light onto the retina. When disease, injury or degeneration damages it — making it cloudy, scarred or misshapen — no glasses or drops can compensate, because the problem lies in the optical surface itself.
Conditions that lead to corneal transplantation include:
Important: not every patient who is told they need a corneal transplant actually needs one as the first step. In keratoconus, for example, corneal cross-linking (C3R) at an early stage can halt progression and avoid transplantation altogether. Our specialist reviews your case with this in mind.
This is the clinical heart of the page and the decision that matters most. Modern cornea surgery has moved decisively away from replacing the whole cornea when only part of it is diseased. The principle is precision: replace only the layer that is damaged, preserving what is healthy. This reduces rejection risk, speeds recovery and often gives better optical outcomes.
The surgeon removes the full thickness of the central cornea using a circular trephine and sutures in the full-thickness donor button. PK is the traditional technique and remains the right choice for conditions where the damage runs all the way through the cornea — deep scarring from trauma or infection, advanced bullous keratopathy, or keratoconus cases where the back layer is also compromised. Healing takes the longest of the techniques: vision improves over 6–12 months as sutures remain in place and the graft settles. The rejection risk is higher than with lamellar techniques, and regular anti-rejection drops are needed long-term.
Graft survival: approximately 80–90% at 1 year; 60–75% at 5 years depending on the underlying cause. Better outcomes are seen for keratoconus and non-infectious corneal scars than for vascular disease or re-grafts.
DALK replaces the front stroma of the cornea while leaving the patient's own Descemet's membrane and endothelium (the inner layer and its cells) in place. Because the endothelium — the layer most involved in immune rejection — is not replaced, rejection risk is dramatically lower than with PK. DALK is the graft of choice for keratoconus and anterior corneal scars where the back layer remains healthy. Recovery is faster than PK (typically 2–4 months for meaningful vision), and even if the graft fails, the patient's own endothelium is preserved — a significant advantage for future re-grafting.
DALK is technically more demanding than PK and requires an experienced corneal surgeon. It is available at leading centres in India but not universally.
DSEK replaces only the diseased endothelial layer and its supporting tissue. The surgeon peels away the patient's damaged endothelium and inserts a thin button of donor posterior stroma and endothelium through a small incision, positioning it with an air bubble. Most of the patient's cornea is left intact. The procedure is ideal for Fuchs' dystrophy and other conditions causing endothelial cell failure. Recovery is faster than PK — most patients see meaningful improvement within 1–3 months. The DSEK graft is slightly thicker than DMEK, which makes it easier to handle and insert, making it the preferred choice in many centres.
DMEK is the most refined endothelial technique. Instead of transplanting a thick tissue disc as in DSEK, the surgeon transplants only the ultra-thin Descemet's membrane and a single layer of endothelial cells — a tissue sheet no thicker than a human hair. The result is the fastest visual recovery (many patients achieve good vision within weeks rather than months) and the lowest risk of immune rejection of any corneal transplant technique. DMEK and DSEK procedures have the highest success rates, often exceeding 90%, due to their tissue-selective approach and lower risk of rejection.
The trade-off is technical difficulty: DMEK is demanding to prepare, deliver and unfold inside the eye. It is available at the most experienced corneal centres; your surgeon's skill with DMEK specifically is the most important single factor in outcomes.
A key innovation since 2007: the adoption of lamellar techniques (DALK, DSEK, DMEK) has allowed one donor cornea to restore sight in up to two recipients — one patient receiving the anterior tissue and another the posterior — dramatically improving the effective utilisation of available donor tissue.
When a patient has had multiple failed grafts, or when severe autoimmune disease or chemical burns make conventional tissue transplantation impossible, an artificial cornea (keratoprosthesis — KPro) can still restore meaningful vision. This is a specialised procedure available at a small number of centres and is reserved for the most complex cases. Cost and planning are quoted individually.
India has one of the largest eye-banking systems in the world. As of 2023, around 740 members are registered under the Eye Bank Association of India — including dedicated eye banks, eye donation centres and eye bank training centres. The NPCB's national corneal blindness control programme has worked for decades to build this infrastructure, with government support for operational costs and donor recruitment.
At the leading private eye centres and dedicated ophthalmology institutions that form MediGoCare's partner network — including facilities in Delhi NCR, Mumbai, Bengaluru, Hyderabad and Chennai — donor tissue is typically available from accredited eye banks with rigorous screening protocols. Every donor cornea is assessed for endothelial cell count, clarity and infectious disease markers before being released for transplantation.
An important honest note: India's eye-bank system has grown significantly, and at leading centres tissue waiting times are considerably shorter than in many Western countries. However, demand does exceed supply at a national level, particularly in rural areas and smaller cities. This is why we specifically arrange surgery at our accredited partner hospitals in major cities, where eye-bank relationships are established and tissue availability for planned cases is reliable. We confirm tissue availability as part of your treatment planning, not as an afterthought.
For most planned PK and lamellar procedures at our partner centres, waiting times for suitable donor tissue are measured in days to weeks rather than months — a meaningful contrast with NHS queues that can extend to a year or more.
Corneal transplantation has some of the highest success rates of any transplant procedure in medicine. According to studies published in the Indian Journal of Ophthalmology and data from the All India Ophthalmological Society, penetrating keratoplasty for keratoconus achieves graft survival rates exceeding 90% at five years. For Fuchs' dystrophy treated with DMEK, success rates are similarly high — around 90–95% — with faster visual recovery. India's average success rate across techniques ranges between 85% and 95%, especially in well-matched cases with healthy donor tissue.
That said, corneal transplantation is a journey, not a single event. Understanding what happens after surgery is as important as the surgery itself.
Rejection: The immune system can recognise the donor tissue as foreign and mount a rejection episode, typically causing redness, pain, light sensitivity and sudden blurring. Rejection affects around 5–10% of corneal transplants. The crucial point: most rejection episodes are reversible if caught early and treated promptly with steroid drops. This is why regular follow-up — and knowing the warning signs — matters throughout the first few years. DMEK and DSEK carry lower rejection risk than PK because less foreign tissue is introduced.
Anti-rejection drops: All corneal transplant patients use topical steroid eye drops for months to years after surgery, gradually tapering. These are a non-negotiable part of graft survival. We arrange adequate supply for your journey home and prescribe a clear tapering schedule.
Recovery by technique:
| Technique | Meaningful vision | Full graft settlement |
|---|---|---|
| DMEK | 1–3 months | 3–6 months |
| DSEK | 1–3 months | 3–6 months |
| DALK | 2–4 months | 6–12 months |
| PK | 6–12 months | Up to 18 months |
Final vision after PK is often not reached until sutures are selectively removed — a process that can take 12–18 months. After endothelial keratoplasty (DMEK/DSEK), recovery is substantially faster because sutures are not required and the corneal surface is undisturbed.
Will you need glasses? Usually yes, to some degree. Corneal transplantation restores corneal clarity; it does not automatically give perfect unaided vision. Most patients need glasses or contact lenses for fine-tuned vision after the graft has settled. Refractive surgery to reduce glasses dependence is sometimes possible years after a successful transplant.
Long-term follow-up: Corneal grafts can remain clear for 10 years, 20 years or more — but they require ongoing vigilance. Annual reviews with an ophthalmologist, prompt treatment of any rejection signs, and continued care of the eye are part of the commitment. MediGoCare arranges your teleconsultation follow-up schedule so you are never left managing this alone after returning home.
For most corneal transplant procedures, an initial stay of 10–14 days in India is recommended. This covers your pre-operative assessment and tissue matching, the surgery itself, and the first critical post-operative period — including the Day 1 review and a further check before you fly. Longer stays are occasionally needed for complex cases or if tissue availability requires a short wait.
Corneal transplantation requires genuine sub-speciality expertise — particularly for the technically demanding DMEK and DALK procedures. The number of grafts a surgeon has performed, the centre's eye-bank relationships and post-operative monitoring protocols matter as much as the surgical technique itself.
Through MediGoCare's partner network — which includes Fortis, Apollo, Max, Artemis, Manipal, Kokilaben, Aster, Sarvodaya and MGM Healthcare — you are placed with senior corneal surgeons at accredited centres with established eye-bank access. For patients specifically seeking an experienced refractive and corneal specialist, we can facilitate access to Dr Suraj Munjal, Founder and Chief Eye Surgeon at The Sight Avenue, Delhi NCR — who has performed thousands of successful corneal transplants using DMEK, DSEK and penetrating keratoplasty.
India is also home to some of the world's leading dedicated corneal institutions — L V Prasad Eye Institute in Hyderabad, Sankara Nethralaya in Chennai and Narayana Nethralaya in Bengaluru — which are internationally recognised for corneal research and surgical outcomes. Where a case requires tertiary-level corneal expertise, we discuss the right centre for your specific diagnosis.
See our best eye hospitals in India guide for a full comparison, or send your diagnosis and scans on WhatsApp and we'll match you directly to the right surgeon and centre.
Send your diagnosis, corneal scans or a description of your condition on WhatsApp (+91 90858 83067) for a specialist opinion and an all-inclusive quote. You can also request a free assessment or a callback. Most patients receive a specialist opinion and a confirmed treatment plan within 24–48 hours of their first message.
For the full picture on all eye procedure costs, see our eye surgery cost in India guide.
Cornea transplant cost in India ranges from about ₹50,000 to ₹2,50,000 (roughly USD 600–3,000) per eye depending on the technique — PK, DALK, DSEK or DMEK. This is far below the USD 13,000–27,000 typical in the United States or £6,000–£12,000 in the UK private sector. Your all-inclusive quote from MediGoCare specifies the technique and what's included.
India's leading eye centres report graft success rates of 85–95%. DMEK and DSEK for endothelial disease achieve up to 90–95% success with lower rejection risk. PK for keratoconus achieves graft survival exceeding 90% at five years at specialist centres. Many grafts remain clear for a decade or more with proper follow-up.
At leading accredited centres in major cities — which form MediGoCare's partner network — donor tissue for planned cases is typically available within days to weeks, considerably shorter than NHS queues in the UK. Every donor cornea is screened for infectious disease and graded for quality before use.
Rejection is possible but often preventable and usually reversible if treated early — which is why anti-rejection drops and regular follow-up matter throughout the first years. Around 5–10% of corneal transplants experience a rejection episode; most resolve fully with prompt steroid treatment. DMEK and DSEK carry lower rejection risk than full-thickness PK because less foreign tissue is introduced.
Both replace only the failed endothelial layer. DMEK uses an ultra-thin graft and typically gives faster, sharper visual recovery; DSEK uses a slightly thicker disc that is technically easier to handle. The choice depends on your corneal anatomy and the surgeon's skill with each technique. Your surgeon recommends the best fit for your specific eye after reviewing your case.
A whole-eye transplant is not currently possible in medicine. What restores vision when the cornea is damaged is a corneal transplant (keratoplasty) — replacing only the damaged front surface of the eye with healthy donor tissue. The rest of your eye, including the retina, optic nerve and lens, remains your own.
It depends on the technique. DMEK and DSEK patients often see meaningful improvement within one to three months. DALK patients typically recover over two to four months. PK patients usually wait 6–12 months for good vision, as sutures remain in place during healing and are selectively removed over time. Final vision — including a glasses prescription — is measurable once the graft has fully settled.
Most patients need glasses or contact lenses for fine-tuned vision after the graft settles. Corneal transplantation restores clarity, not necessarily perfect unaided acuity. Refractive surgery to reduce residual glasses dependence is sometimes possible years after a successful transplant, once the cornea has fully stabilised.
Medical disclaimer: This page is for general information and does not constitute medical advice or replace a consultation with a qualified ophthalmologist. Suitability for corneal transplantation, choice of graft type, and tissue availability must be assessed by a specialist. Cost figures are indicative estimates; exact prices are confirmed after specialist review. Last reviewed: June 2026.
24/7 Assistance with the best medical care at your service
Quality treatment with professional & unmatched personal care
Our experts make your Communication easier and more transparent